استخدام البروستاغلاندين E1 تحت اللسان لإنهاء الحمل بثلثيه الثاني والثالث

Authors

  • جهاد الأيوب
  • حسن صالح
  • سهاد علي

Abstract

الهدف من الدراسة: تقييم فعالية وأمان إعطاء البروستاغلاندين E1 (ميزوبروستول)  تحت اللسان لإنهاء الحمل. الطريقة : شملت الدراسة 82 مريضة, قسمت إلى 52 مريضة في الثلث الثاني للحمل و30 مريضة في الثلث الثالث, وأعطيت المجموعتين  50mcg تحت اللسان كل أربع ساعات (4جرعات) وجاءت النتائج:

-  مدة التحريض الفعال13.4±2 ساعة في الثلث الثاني للحمل و14.5± 2ساعة في الثلث الثالث. ومعدل الإسقاط أو الولادة المهبلية %50 في الثلث الثاني و% 93.33 في الثلث الثالث. أما الآثار الجانبية فكانت:

-   الغثيان (%1.9). التوهج (%1.9) في الثلث الثاني.

-   الغثيان (%3.3), التوهج (%3.3), الألم البطني (%10), فرط الاستثارة الرحمية (%3.3), تألم الجنين (%3.3) في الثلث الثالث للحمل.

The objective of this study is evaluate the effectiveness and safety of sublingual administration of Misoprostol for pregnancy termination. The study included 82 patients, who were divided into two groups: 52 patients in second Trimester, and 30 patients in third trimester. The two groups used Misoprostol 50mcg sublingually every 4 hours (4 doses).

The study shows that the mean duration of induction was13.4±2 hours in group 1 and 14.5±2 hours in group 2. The incidence of abortion or vaginal delivery was 50% in group1, and 93.33% in group 2 . the side effects were :

Nausea (1.9%) and flashing (1.9%) in group 1 .

Nausea (3.3%), Flashing (3.3%), Abdominal pain (10%), Uterine Hyperstimulation (3.3%), and Fetal distress(3.3%) in group 2 .

Downloads

Published

2019-01-16

How to Cite

1.
الأيوب ج, صالح ح, علي س. استخدام البروستاغلاندين E1 تحت اللسان لإنهاء الحمل بثلثيه الثاني والثالث. Tuj-hlth [Internet]. 2019Jan.16 [cited 2024Dec.28];29(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6494

Issue

Vol. 29 No. 4 (2007): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 3 > >>